Detalhe da pesquisa
1.
A phase 1b study of the allosteric extracellular FGFR2 inhibitor alofanib in patients with pretreated advanced gastric cancer.
Invest New Drugs
; 41(2): 324-332, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36907947
2.
Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients.
Int J Mol Sci
; 24(3)2023 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36768191
3.
Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance.
Curr Treat Options Oncol
; 23(12): 1664-1698, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36269457
4.
Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial.
Breast Cancer Res Treat
; 188(3): 631-640, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34148205
5.
An Open-Label Study of the Safety and Efficacy of Tag-7 Gene-Modified Tumor Cells-Based Vaccine in Patients with Locally Advanced or Metastatic Malignant Melanoma or Renal Cell Cancer.
Oncologist
; 25(9): e1303-e1317, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32240562
6.
Efficacy of immune checkpoint blockade in MUTYH-associated hereditary colorectal cancer.
Invest New Drugs
; 38(3): 894-898, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31377904
7.
CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial.
Lancet Oncol
; 18(7): 917-928, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28592386
8.
A Phase III Study of Balugrastim Versus Pegfilgrastim in Breast Cancer Patients Receiving Chemotherapy With Doxorubicin and Docetaxel.
Oncologist
; 21(1): 7-15, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26668251
9.
Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Survey Comparison of Physicians and Patients.
Oncologist
; 21(3): 292-300, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26888693
10.
Quality of life in the trastuzumab for gastric cancer trial.
Oncologist
; 19(7): 712-9, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24951609
11.
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial.
Lancet Oncol
; 14(6): 490-9, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23594786
12.
Tumor alkalization therapy: misconception or good therapeutics perspective? - the case of malignant ascites.
Front Oncol
; 14: 1342802, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38390269
13.
Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial.
BioDrugs
; 37(3): 433-440, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881323
14.
NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC.
J Thorac Oncol
; 18(1): 106-119, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240972
15.
Single-dose intravenous casopitant in combination with ondansetron and dexamethasone for the prevention of oxaliplatin-induced nausea and vomiting: a multicenter, randomized, double-blind, active-controlled, two arm, parallel group study.
Support Care Cancer
; 20(7): 1471-8, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21822913
16.
Tumor acidity: From hallmark of cancer to target of treatment.
Front Oncol
; 12: 979154, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36106097
17.
Minimal PK/PD model for simultaneous description of the maximal tolerated dose and metronomic treatment outcomes in mouse tumor models.
Cancer Chemother Pharmacol
; 88(5): 867-878, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351468
18.
Tumor irradiation may facilitate the detection of tumor-specific mutations in plasma.
World J Clin Oncol
; 12(12): 1215-1226, 2021 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35070740
19.
Novel PD-1 inhibitor prolgolimab: expanding non-resectable/metastatic melanoma therapy choice.
Eur J Cancer
; 149: 222-232, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33872982
20.
High efficacy of first-line gefitinib in non-Asian patients with EGFR-mutated lung adenocarcinoma.
Onkologie
; 33(5): 231-8, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20502057